Recorded March 9, 2021 | On-Demand Webinar
Examine preclinical and clinical testing, sources of Good Clinical Practice (GCP) requirements and phases of the clinical trial process. Assess the obligations of sponsors and investigators. Discuss how to interact with FDA. Review compliance and enforcement considerations.
This session was recorded as part of FDLI’s virtual Introduction to Biologics and Biosimilars Law and Regulation course in March 2021.